These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31574863)

  • 1. Adjuvant laser meridian massage in men with opioid use disorder on methadone maintenance treatment: Protocol for a case-controlled study.
    Hu WL; Tsai MC; Kuo CE; Liu CT; Wu SY; Wu TC; Hung YC
    Medicine (Baltimore); 2019 Sep; 98(39):e17319. PubMed ID: 31574863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laser meridian massage decreased craving in men with opioid use disorder on methadone maintenance treatment.
    Hu WL; Tsai MC; Kuo CE; Liu CT; Wu SY; Wu TC; Hung YC
    Biomed J; 2022 Apr; 45(2):414-423. PubMed ID: 35595647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of light needle in the treatment of opioid use disorder: A protocol for a randomized controlled trial.
    Lu TC; Kuo CE; Wu SY; Tsai YH; Hung YC; Hu WL; Tsai MC
    Medicine (Baltimore); 2022 Dec; 101(50):e31451. PubMed ID: 36550884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Acupuncture for Methadone Reduction : A Randomized Clinical Trial.
    Lu L; Chen C; Chen Y; Dong Y; Chen R; Wei X; Tao C; Li C; Wang Y; Fan B; Tang X; Xu S; He Z; Mo G; Liu Y; Gu H; Li X; Cao F; Xu H; Zhang Y; Li G; Liu X; Zeng J; Tang C; Xu N
    Ann Intern Med; 2024 Aug; 177(8):1039-1047. PubMed ID: 38976882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Add-on repetitive transcranial magnetic stimulation in patients with opioid use disorder undergoing methadone maintenance therapy.
    Tsai TY; Wang TY; Liu YC; Lee PW; Chang WH; Lu TH; Tseng HH; Lee SY; Chang YH; Yang Y; Chen PS; Chen KC; Yang YK; Lu RB
    Am J Drug Alcohol Abuse; 2021 May; 47(3):330-343. PubMed ID: 33426970
    [No Abstract]   [Full Text] [Related]  

  • 6. Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial.
    Falcato L; Beck T; Reimer J; Verthein U
    J Clin Psychopharmacol; 2015 Apr; 35(2):150-7. PubMed ID: 25679130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
    Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
    Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
    Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid agonist treatment for pharmaceutical opioid dependent people.
    Nielsen S; Larance B; Degenhardt L; Gowing L; Kehler C; Lintzeris N
    Cochrane Database Syst Rev; 2016 May; (5):CD011117. PubMed ID: 27157143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and Management of Opioid Use Disorder in Hospitalized Patients.
    Herscher M; Fine M; Navalurkar R; Hirt L; Wang L
    Med Clin North Am; 2020 Jul; 104(4):695-708. PubMed ID: 32505261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of cannabis use on opioid agonist treatment outcomes: Exploratory analyses from the OPTIMA study.
    Elkrief L; Bastien G; McAnulty C; Bakouni H; Hébert FO; Socias ME; Le Foll B; Lim R; Ledjiar O; Marsan S; Brissette S; Jutras-Aswad D;
    J Subst Use Addict Treat; 2023 Jun; 149():209031. PubMed ID: 37003540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short term health-related quality of life improvement during opioid agonist treatment.
    Nosyk B; Bray JW; Wittenberg E; Aden B; Eggman AA; Weiss RD; Potter J; Ang A; Hser YI; Ling W; Schackman BR
    Drug Alcohol Depend; 2015 Dec; 157():121-8. PubMed ID: 26511766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FORWARDS-1: an adaptive, single-blind, placebo-controlled ascending dose study of acute baclofen on safety parameters in opioid dependence during methadone-maintenance treatment-a pharmacokinetic-pharmacodynamic study.
    Paterson LM; Barker D; Cro S; Mozgunov P; Phillips R; Smith C; Nahar L; Paterson S; Lingford-Hughes AR
    Trials; 2022 Oct; 23(1):880. PubMed ID: 36258248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment.
    Belcher AM; Cole TO; Greenblatt AD; Hoag SW; Epstein DH; Wagner M; Billing AS; Massey E; Hamilton KR; Kozak ZK; Welsh CJ; Weintraub E; Wickwire EM; Wish ED; Kaptchuk TJ; Colloca L
    BMJ Open; 2019 Jun; 9(6):e026604. PubMed ID: 31230007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South Africa.
    Scheibe A; Shelly S; Gerardy T; von Homeyer Z; Schneider A; Padayachee K; Naidoo SB; Mtshweni K; Matau A; Hausler H; Marks M
    Addict Sci Clin Pract; 2020 Feb; 15(1):13. PubMed ID: 32085807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone.
    Beck T; Haasen C; Verthein U; Walcher S; Schuler C; Backmund M; Ruckes C; Reimer J
    Addiction; 2014 Apr; 109(4):617-26. PubMed ID: 24304412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caring for patients with opioid use disorder in the hospital.
    Donroe JH; Holt SR; Tetrault JM
    CMAJ; 2016 Dec; 188(17-18):1232-1239. PubMed ID: 27647616
    [No Abstract]   [Full Text] [Related]  

  • 18. Substitution treatment for opioid dependence with slow-release oral morphine: Retention rate, health status, and substance use after switching to morphine.
    Lehmann K; Kuhn S; Baschirotto C; Jacobsen B; Walcher S; Görne H; Backmund M; Scherbaum N; Reimer J; Verthein U
    J Subst Abuse Treat; 2021 Aug; 127():108350. PubMed ID: 34134867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of Web-Based Single-Session Empowered Relief in Patients With Chronic Pain Taking Methadone or Buprenorphine: Protocol for a Single-Arm Trial.
    Klein MR; Darnall BD; You DS
    JMIR Res Protoc; 2024 Jun; 13():e53784. PubMed ID: 38843513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance Treatment.
    Dennis BB; Roshanov PS; Bawor M; Paul J; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; Thabane L; Samaan Z
    Pain Physician; 2016 Jan; 19(1):E181-95. PubMed ID: 26752486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.